Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Trading Statement

21 Oct 2010 07:00

RNS Number : 7190U
Impellam Group plc
21 October 2010
 



Impellam Group plc

("Impellam", the "Company" or the "Group")

 

Trading Update

 

On 6 August 2010 the Company announced its unaudited interim results for the 26 weeks ended 2 July 2010 which stated that operating profit had increased to £12.5m (2009 £0.5m). Net debt had decreased by £30.4 million to £39.2 million as at 2 July 2010 as a result of significant cash generation for the period.

 

Since the interim period end, Impellam has continued to see improved operating performance consistent with the trends experienced during the first half of the year. Net debt stands at £28.5m at 1 October 2010.

 

Cheryl Jones, Chairman, commented:

 

"For the trading period following the Groups half year end, the Company has seen operating performance improvement consistent with that experienced during the first half of the year. Efficiency programs and business rationalization have continued across the Group, and the Company continues to prioritize key drivers of our plan which include leveraging our brands, further improving our process and technology environments, investing in service innovation and refining our growth strategy."

 

 

Enquiries: For any further information please contact:

Impellam Group plc

Cheryl Jones, Chairman

Andrew Burchall, Group Finance Director

Tel: 01582 692658

Tel: 01582 692658

Cenkos Securities plc (Nominated Advisor and Broker to Impellam)

Nicholas Wells

Elizabeth Bowman

Tel: 020 7397 8900

Tel: 020 7397 8900

 

 

Note to Editors:

Impellam is traded on AIM (Symbol: IPEL) and is a leading provider of staffing solutions, human capital management and outsourced people-related services with established operations in the UK, Ireland, USA, mainland Europe, Australia and New Zealand.

 

Business Segment

Staffing Sectors/Brands

Healthcare Staffing

The Group's Healthcare staffing segment comprises Medacs Healthcare (locum doctors, nursing, international recruitment and managed healthcare services) and Chrysalis Homecare (domiciliary care).

UK Staffing - Commercial

 

The Group's UK Commercial staffing segment primarily includes those brands that operate in the traditional clerical, administrative, industrial/trades and hospitality staffing markets. These principal brands include ABC Contract Services (construction and telecoms), Blue Arrow (catering, managed services, office and industrial), Carlisle Managed Solutions (managed services), Comensura (vendor neutral staffing & recruitment procurement), and Tate (office).

UK Staffing - Professional & Technical

 

The Group's UK Professional & Technical staffing segment comprises the following principal brands: Austin Benn (sales and marketing), Celsian Education (teachers and school support staff), Chadwick Nott (legal), Hewitson Walker (accounting), IRC (multi-sector staffing in Ireland), S∙COM (technical) and SRG (scientific).

US Staffing

The Group's US staffing segment operates across a wide spectrum of staffing sectors. The principal brands and their specialties include CORESTAFF Services and Leafstone (Call centre/customer care, engineering, IT, light industrial, office/clerical, professional, skilled trade and technical), Guidant Group (managed services), InfoCurrent (information/records management and library services), S∙COM (technical and telecom) and SRG Woolf (clinical research).

Support Services

The Group's Support services segment consists of several brands providing a wide range of outsourced services to clients throughout the UK. These brands include Carlisle Cleaning & Support Services (contract cleaning and facility support services), Carlisle Security (security guarding and CCTV public space surveillance), and the Recruit (retail merchandising and events).

 

- END-

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXBLFLBBFLFBE
Date   Source Headline
22nd Nov 202311:40 amRNSForm 8.5 (EPT/RI)
22nd Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
21st Nov 20232:06 pmRNSForm 8.3 - Impellam Group Plc
21st Nov 202310:46 amRNSForm 8.5 (EPT/RI)
21st Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
16th Nov 202311:46 amRNSForm 8.3 - Impellam Group PLC
16th Nov 202311:24 amRNSForm 8.5 (EPT/RI)
16th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
15th Nov 20231:33 pmRNSForm 8.3 - Impellam Group Plc
15th Nov 20239:29 amRNSForm 8.5 (EPT/RI)
15th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
14th Nov 202312:36 pmRNSForm 8.3 - Impellam Group Plc
14th Nov 202310:34 amRNSForm 8.5 (EPT/RI)
14th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
13th Nov 202311:51 amRNSForm 8.3 - Impellam Group Plc
13th Nov 202311:39 amRNSForm 8.5 (EPT/RI)
13th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
10th Nov 202312:16 pmRNSForm 8.3 - Impellam Group Plc
10th Nov 202310:37 amRNSForm 8.5 (EPT/RI)
10th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
9th Nov 202311:45 amRNSForm 8.3 - Impellam Group PLC
8th Nov 20235:46 pmRNSPUSU Extension and Interim Dividend
8th Nov 20234:07 pmRNSExtension of PUSU Deadline
8th Nov 20232:04 pmRNSForm 8.3 - Impellam Group PLC
7th Nov 202312:29 pmRNSForm 8.3 - Impellam Group PLC
7th Nov 202311:02 amRNSForm 8.5 (EPT/RI)
7th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
6th Nov 202310:45 amRNSForm 8.3 - Impellam Group PLC
3rd Nov 202311:18 amRNSForm 8.3 - Impellam Group PLC
3rd Nov 20239:22 amRNSForm 8.5 (EPT/RI)
3rd Nov 20237:05 amRNSTransaction in Own Shares & Rule 2.9 Announcement
2nd Nov 202312:09 pmRNSForm 8.3 - Impellam Group PLC
2nd Nov 20239:57 amRNSForm 8.5 (EPT/RI)
2nd Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
1st Nov 20232:21 pmRNSForm 8.3 - Impellam Group PLC
1st Nov 202310:30 amRNSForm 8.5 (EPT/RI)
1st Nov 20238:30 amRNSTransaction in Own Shares & Rule 2.9 Announcement
1st Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
31st Oct 202311:28 amRNSForm 8.3 - Impellam Group PLC
30th Oct 202312:35 pmRNSForm 8.3 - Impellam Group PLC
26th Oct 202310:45 amRNSForm 8.5 (EPT/RI)
26th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
25th Oct 20233:41 pmRNSExtension of PUSU Deadline
25th Oct 202311:47 amRNSForm 8.5 (EPT/RI)
25th Oct 202311:17 amRNSForm 8.3 - Impellam Group plc
25th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
24th Oct 202311:07 amRNSForm 8.5 (EPT/RI)
24th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Oct 202311:13 amRNSForm 8.5 (EPT/RI)
17th Oct 202311:38 amRNSForm 8.3 - Impellam Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.